-
Code of Conduct & Corporate Values
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.
Code of Conduct & Corporate Values
Code of Conduct
Our Board of Directors has adopted a
comprehensive Code of Conduct that is
applicable to all of our directors, officers, and employees.
Code of Conduct and Corporate Values
California Compliance Declaration
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) |  | +0.04 | |
| Volume | 652143 | ||
| 10:22 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
12-31-1969
Enzon Reports Strong First Qua...
Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure-- -
04-29-2009
Enzon to Release First Quarter...
Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
04-30-2008
Enzon to Release First Quarter...
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow
-
12-31-1969
Enzon Reports Strong First Qua...
Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure-- -
05-06-2009
Enzon Reaches Phase II Dose fo...
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027-- -
07-02-2008
Enzon Eliminates its Remaining...
Enzon Eliminates its Remaining 2008 Debt
-
05-20-2008
Enzon Announces Clinical Data...
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --